Annual Accounts Payable
$9.45 M
+$4.15 M+78.39%
June 30, 2024
Summary
- As of March 14, 2025, RENB annual accounts payable is $9.45 million, with the most recent change of +$4.15 million (+78.39%) on June 30, 2024.
- During the last 3 years, RENB annual accounts payable has risen by +$9.13 million (+2847.19%).
- RENB annual accounts payable is now at all-time high.
Performance
RENB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$10.93 M
-$467.60 K-4.10%
December 31, 2024
Summary
- As of March 14, 2025, RENB quarterly accounts payable is $10.93 million, with the most recent change of -$467.60 thousand (-4.10%) on December 31, 2024.
- Over the past year, RENB quarterly accounts payable has increased by +$1.49 million (+15.73%).
- RENB quarterly accounts payable is now -4.10% below its all-time high of $11.40 million, reached on September 30, 2024.
Performance
RENB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
RENB Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +78.4% | +15.7% |
| 3 y3 years | +2847.2% | +15.7% |
| 5 y5 years | +1654.3% | +15.7% |
RENB Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2847.2% | -4.1% | +2145.3% |
| 5 y | 5-year | at high | +2847.2% | -4.1% | +6455.5% |
| alltime | all time | at high | +2847.2% | -4.1% | >+9999.0% |
Renovaro Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $10.93 M(-4.1%) |
| Sep 2024 | - | $11.40 M(+20.7%) |
| Jun 2024 | $9.45 M(+78.4%) | $9.45 M(+18.2%) |
| Mar 2024 | - | $7.99 M(+43.3%) |
| Dec 2023 | - | $5.58 M(+2.9%) |
| Sep 2023 | - | $5.42 M(+2.3%) |
| Jun 2023 | $5.30 M(+277.8%) | - |
| Jun 2023 | - | $5.30 M(+18.5%) |
| Mar 2023 | - | $4.47 M(-1.8%) |
| Dec 2022 | - | $4.56 M(-2.7%) |
| Sep 2022 | - | $4.68 M(+234.0%) |
| Jun 2022 | $1.40 M(+337.3%) | $1.40 M(+187.9%) |
| Mar 2022 | - | $487.00 K(+192.0%) |
| Dec 2021 | - | $166.80 K(-69.6%) |
| Sep 2021 | - | $547.90 K(+70.9%) |
| Jun 2021 | $320.60 K(-45.9%) | $320.60 K(-36.5%) |
| Mar 2021 | - | $504.90 K(+167.3%) |
| Dec 2020 | - | $188.90 K(-33.1%) |
| Sep 2020 | - | $282.40 K(-52.4%) |
| Jun 2020 | $592.90 K(+10.1%) | $592.90 K(+80.5%) |
| Mar 2020 | - | $328.40 K(-47.7%) |
| Dec 2019 | - | $628.00 K(+3.0%) |
| Sep 2019 | - | $609.60 K(+13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | $538.60 K(-5.8%) | $538.60 K(-57.6%) |
| Mar 2019 | - | $1.27 M(+68.5%) |
| Dec 2018 | - | $753.90 K(+5.7%) |
| Sep 2018 | - | $713.10 K(+24.7%) |
| Jun 2018 | $571.80 K(-14.7%) | $571.80 K(-36.4%) |
| Mar 2018 | - | $898.60 K(-3.8%) |
| Dec 2017 | - | $933.80 K(+109.9%) |
| Sep 2017 | - | $444.90 K(-33.6%) |
| Jun 2017 | $670.00 K(-43.5%) | $670.00 K(-45.5%) |
| Mar 2017 | - | $1.23 M(+15.4%) |
| Dec 2016 | - | $1.06 M(-1.1%) |
| Sep 2016 | - | $1.08 M(-9.1%) |
| Jun 2016 | $1.19 M(+34.9%) | $1.19 M(+49.1%) |
| Mar 2016 | - | $794.70 K(+27.5%) |
| Dec 2015 | - | $623.20 K(-30.2%) |
| Sep 2015 | - | $893.20 K(+8.5%) |
| Jun 2015 | $878.80 K(-4.9%) | - |
| Mar 2015 | - | $823.00 K(-10.9%) |
| Dec 2014 | $923.90 K | $923.90 K(+48.1%) |
| Sep 2014 | - | $624.00 K(-6.7%) |
| Jun 2014 | - | $668.90 K(+17.7%) |
| Mar 2014 | - | $568.20 K(>+9900.0%) |
| Dec 2011 | - | $400.00 |
FAQ
- What is Renovaro Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Renovaro Biosciences?
- What is Renovaro Biosciences annual accounts payable year-on-year change?
- What is Renovaro Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly accounts payable year-on-year change?
What is Renovaro Biosciences annual accounts payable?
The current annual accounts payable of RENB is $9.45 M
What is the all time high annual accounts payable for Renovaro Biosciences?
Renovaro Biosciences all-time high annual accounts payable is $9.45 M
What is Renovaro Biosciences annual accounts payable year-on-year change?
Over the past year, RENB annual accounts payable has changed by +$4.15 M (+78.39%)
What is Renovaro Biosciences quarterly accounts payable?
The current quarterly accounts payable of RENB is $10.93 M
What is the all time high quarterly accounts payable for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly accounts payable is $11.40 M
What is Renovaro Biosciences quarterly accounts payable year-on-year change?
Over the past year, RENB quarterly accounts payable has changed by +$1.49 M (+15.73%)